Dr. Lal Pathlabs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020
January 29, 2021 at 05:32 am
Share
Dr. Lal PathLabs Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 4,659 million compared to INR 3,417 million a year ago. Net income was INR 945 million compared to INR 541 million a year ago. Basic earnings per share from continuing operations was INR 11.44 compared to INR 6.56 a year ago. Diluted earnings per share from continuing operations was INR 11.41 compared to INR 6.55 a year ago. For the nine months, total revenue was INR 11,881 million compared to INR 10,717 million a year ago. Net income was INR 2,082 million compared to INR 1,934 million a year ago. Basic earnings per share from continuing operations was INR 25.23 compared to INR 23.48 a year ago. Diluted earnings per share from continuing operations was INR 25.16 compared to INR 23.42 a year ago.
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
DR. LAL PATHLABS LIMITED 
